Survey of cryoprecipitate production and cryoprecipitate and fibrinogen concentrate utilization in North America: Variable practices observed from July 2016 to June 2021, The BEST Collaborative Study

Documenti analoghi

• The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
  di: Aaron S. Hess, et al.
  Pubblicazione: (2026)
• Implementation of pathogen reduced cryoprecipitate for surgical services: A retrospective review of blood product utilization and fibrinogen repletion
  di: Joshua Nicholas, et al.
  Pubblicazione: (2025)
• Retention of critical platelet hemostatic functions of amotosalen‐ UVA pathogen‐reduced cryoprecipitated fibrinogen complex
  di: Florian Tupin, et al.
  Pubblicazione: (2026)
• How do we maintain a dual inventory of room temperature stored platelets with cold‐stored platelets?
  di: Claudia S. Cohn, et al.
  Pubblicazione: (2025)
• Transfusion service staff and anesthesiologists prefer pathogen‐reduced cryoprecipitate over conventional cryoprecipitated antihemophilic factor
  di: Robert A. DeSimone, et al.
  Pubblicazione: (2025)